SCHEMBL206734

SCHEMBL206734

C=CCOc1ccc(CN2CCN(C(=O)CCC(=O)NC3CCC(Cc4cccc(C)c4)(N(C)C)CC3)CC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SSTR1 P30872 1/20 0.39
SSTR4 P31391 1/20 0.39
SIGMAR1 Q99720 2/20 0.38
YAP1 P46937 1/20 0.38
POLB P06746 1/20 0.38
DRD4 P21917 1/20 0.38
DCUN1D1 Q96GG9 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
USP2 O75604 1/20 0.37
ADIPOR2 Q86V24 1/20 0.37
ADIPOR1 Q96A54 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205971 0.83 CXCR4 (0.46) ALDH1A1HTTKDM4EMEN1KMT2A
SCHEMBL5158319 0.83 YAP1 (0.34) ALDH1A1KDM4ESIGMAR1YAP1
SCHEMBL205663 0.82 MEN1 (0.49) ALDH1A1HTTKDM4EMEN1KMT2A
SCHEMBL208523 0.80 SSTR1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2SSTR1
SCHEMBL4072326 0.79 SIGMAR1 (0.49) MEN1KMT2ASIGMAR1DRD4
SCHEMBL207144 0.78 ADAMTS4 (0.47) MEN1KMT2ASSTR1SSTR4SIGMAR1
SCHEMBL207062 0.78 KMT2A (0.47) ALDH1A1HTTKDM4EMEN1KMT2A
SCHEMBL205785 0.77 MEN1 (0.43) ALDH1A1MEN1KMT2ASSTR1SSTR4
SCHEMBL205707 0.77 FAAH (0.49) ALDH1A1KDM4EMEN1KMT2ASSTR1
SCHEMBL207068 0.76 USP2 (0.50) HTTSMN1; SMN2POLBTDP1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885HTT 422/4885KDM4E 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.